Evidence map›Paper›PMID 35078210›Full record

SynthesisThe international journal of neuropsychopharmacology2022

Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review.

Nathan T M Huneke, Ibrahim H Aslan, Harry Fagan, Naomi Phillips, Rhea Tanna, Samuele Cortese, Matthew Garner, David S Baldwin

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in The international journal of neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Placebo and nocebo effect in pain.Handbook of clinical neurology · 2025
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Nathan T M HunekeClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0001-5981-6707
Ibrahim H AslanClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Harry FaganSouthern Health National Health Service Foundation Trust, Southampton, UK.
Naomi PhillipsSolent National Health Service Trust, Southampton, UK.
Rhea TannaSouthern Health National Health Service Foundation Trust, Southampton, UK.
Samuele CorteseSolent National Health Service Trust, Southampton, UK.
Matthew GarnerClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
David S BaldwinClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
National Health Service · GBUniversity of Southampton · GB

Funding

Medical Research Council MR/T000902/1
6 · The paper itself

Abstract

backgroundThe mechanisms underlying placebo effects of psychotropic drugs remain poorly understood. We carried out the first, to our knowledge, systematic review of functional neuroimaging correlates of placebo response in adults with anxiety/depressive disorders.

methodsWe systematically searched a large set of databases up to February 2021 based on a pre-registered protocol (PROSPERO CRD42019156911). We extracted neuroimaging data related to clinical improvement following placebo or related to placebo mechanisms. We did not perform a meta-analysis due to the small number of included studies and significant heterogeneity in study design and outcome measures.

resultsWe found 12 relevant studies for depressive disorders and 4 for anxiety disorders. Activity in the ventral striatum, rostral anterior cingulate cortex and other default mode network regions, orbitofrontal cortex, and dorsolateral prefrontal cortex correlated with placebo antidepressant responses. Activity in regions of the default mode network, including posterior cingulate cortex, was associated with placebo anxiolysis. There was also evidence for possible involvement of the endogenous opioid, dopamine, and serotonin systems in placebo antidepressant and anxiolytic effects.

conclusionsSeveral brain regions and molecular systems may be involved in these placebo effects. Further adequately powered studies exploring causality and controlling for confounders are required.

Indexed as

Functional NeuroimagingPlacebo EffectAdultAntidepressive AgentsAnxiety DisordersHumansNeuroimagingAntidepressive Agentsanxietydepressionfunctional neuroimagingPlacebo response

Identifiers

PMID35078210
PMCPMC9211006
OpenAlexW4207004287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.